The EVP, COO & Pres-CooperVision of Cooper Co is Exercising Options


Today it was reported that the EVP, COO & Pres-CooperVision of Cooper Co (NYSE: COO), Daniel Mcbride, exercised options to sell 10,310 COO shares at $95.74 a share, for a total transaction value of $2.73M.

Following Daniel Mcbride’s last COO Sell transaction on July 02, 2018, the stock climbed by 28.9%. In addition to Daniel Mcbride, 3 other COO executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Cooper Co’s latest earnings report for the quarter ending July 31, the company posted quarterly revenue of $660 million and quarterly net profit of $101 million. In comparison, last year the company earned revenue of $556 million and had a net profit of $104 million. COO’s market cap is $13.02B and the company has a P/E ratio of 104.67. Currently, Cooper Co has an average volume of 289.5K.

One of the top 25 analysts, according to TipRanks.com, recently recommended Buy COO with a $280 price target. Based on 5 analyst ratings, the analyst consensus is Strong Buy with an average price target of $285.60, reflecting a 7.6% upside.

The insider sentiment on Cooper Co has been negative according to 45 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Daniel Mcbride’s trades have generated a -26.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

The Cooper Cos, Inc. operates as a medical device company. It operates through the following business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts